In this renewal application of an established (38 years), successful multidisciplinary training program in Digestive Diseases, we will continue to train qualified postdoctoral individuals (M.D., and/or Ph.D.) for academic careers in digestive diseases. Our interdisciplinary, full time faculty of 40 scientists supports two tracks for potentil trainees: i) basic/disease oriented research;and ii) patient-oriented research. The basic/disease oriented tract remains one of long-standing excellence with training opportunities in cancer cell biology, enteric neurosciences, liver pathobiology, and new opportunities organized around regenerative medicine/stem cells and transcription/epigenetics. Training in this track is strongly supported through interactions with the NIH funded Mayo Comprehensive Cancer Center, Basic Science Departments at Mayo Clinic, and the newly acquired NIH P30 Digestive Disease Center grant. The patient-oriented tract, which is educationally buttressed through the Mayo Center for Translational Science Activities (CTSA), maintains training opportunities in human genetics/epidemiology, obesity/nutrition, human imaging/physiology, and a newly developed track in the science of healthcare delivery/comparative effectiveness, the latter being a new area of institutional focus. The initiative in obesity/nutrition proposed in the last renewal has been remarkably successful with 3 new trainees in this track. We continue to request support for 5 postdoctoral trainees/year that are selected through objective and consensus-driven mechanisms from a talented annual pool of approximately 75 M.D., PhD, or M.D./PhD candidates derived from a variety of clinical and basic disciplines. The overall success of the program continues to be outstanding with 65% of trainees from the most recently completed 10-year cohort (n=23) entering into an academic medicine staff appointment and a funding portfolio from this cohort that includes 16 new federal grants (5 K series, 9 R series, 2 P30 pilots). Our aggressive recruitment of both female and underrepresented minority candidates also continues, with 50% of the trainees from female (38%) or minority groups (12%) during the last 10 years. Institutional support also continues to be strong and well documented. Thus, this highly established training program remains creative, innovative, and dynamic, thereby continuing to be highly successful in achieving its goal of training individuals for academic careers in gastroenterology and hepatology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007198-39S1
Application #
8898324
Study Section
Special Emphasis Panel (ZDK1-GRB-2 (J2))
Program Officer
Densmore, Christine L
Project Start
1979-01-01
Project End
2018-12-31
Budget Start
2014-01-15
Budget End
2014-12-31
Support Year
39
Fiscal Year
2014
Total Cost
$54,918
Indirect Cost
$4,068
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Rizvi, Sumera; Yamada, Daisaku; Hirsova, Petra et al. (2016) A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma. J Biol Chem 291:8031-47
Lalia, Antigoni Z; Dasari, Surendra; Johnson, Matthew L et al. (2016) Predictors of Whole-Body Insulin Sensitivity Across Ages and Adiposity in Adult Humans. J Clin Endocrinol Metab 101:626-34
Cao, H; Eppinga, R D; Razidlo, G L et al. (2016) Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process. Oncogene 35:1099-110
Tabibian, James H; Yang, Ju Dong; Baron, Todd H et al. (2016) Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes. Dig Dis Sci 61:53-61
Johnson, Matthew L; Distelmaier, Klaus; Lanza, Ian R et al. (2016) Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults. Diabetes 65:74-84
Rizvi, Sumera; Borad, Mitesh J (2016) The rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine? J Gastrointest Oncol 7:789-796
Hirsova, Petra; Ibrahim, Samar H; Verma, Vikas K et al. (2016) Extracellular vesicles in liver pathobiology: Small particles with big impact. Hepatology 64:2219-2233
Yang, Ju Dong; Campion, Michael B; Liu, Minetta C et al. (2016) Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma. Hepatology 63:148-58
Johnson, Matthew L; Irving, Brian A; Lanza, Ian R et al. (2015) Differential Effect of Endurance Training on Mitochondrial Protein Damage, Degradation, and Acetylation in the Context of Aging. J Gerontol A Biol Sci Med Sci 70:1386-93
Hickey, Raymond D; Mao, Shennen A; Amiot, Bruce et al. (2015) Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transpl 21:442-53

Showing the most recent 10 out of 138 publications